Long‐term results of permanent urethral stent Memotherm implantation in the management of recurrent bulbar urethral stenosis

Authors:

Abstract
Study Type – Therapy (case series) Level of Evidence 4 What’s known on the subject? and What does the study add? Milroy reported 84% success at a mean of 4.5 years follow‐up by usage of a permanently implantable “urolume” spent in 1993. Memotherm was developed later, especially for urologic use. Our study is one of the largest in this urea, with a high number of patients and a long follow‐up period. OBJECTIVE: • To evaluate the effectiveness and long‐term results of permanent urethral stent (Memotherm) implantation in the treatment of recurrent bulbar urethral stricture. PATIENTS AND METHODS: • In all, 47 patients with a history of previous unsuccessful treatment for bulbar urethral stricture were treated using Memotherm bulbar urethral stents between 1998 and 2002. • Long‐term follow‐up data was analysed and discussed. RESULTS: • At the end of the 7‐year period 37 of 47 patients (78.7%) had been treated successfully. • Post‐micturition dribbling incontinence lasting up to 3 months after stent placement occurred in 32 (68.1%) patients, but this was reduced to only seven patients (14.9%) by the 7‐year follow‐up. • There was stress incontinence of various severities in nine (19.2%) patients at the 1‐year follow‐up. These patients were those who had stenosed urethral segments adjacent to the external sphincter. At the long‐term follow‐up <10% of the patients had stress incontinence complaints. CONCLUSION: • Memotherm is a good treatment option in patients with recurrent bulbar urethral stricture of any cause.

This publication has 7 references indexed in Scilit: